Tag: Clinical Trials
Second COVID-19 Vaccine Trial Paused for Unexplained Illness
Johnson & Johnson stopped its COVID-19 vaccine trial, which began phase 3 testing last month
Older Adults Likely to Be Excluded From COVID-19 Trials
Fifty percent of phase 3 clinical trials and 100 percent of vaccine trials at risk for excluding older adults
New FDA Applications for Opioids Often Based on Short Trials
Most products for treating chronic pain approved based on narrowly defined populations of patients
Most Studies Still Fail to Analyze Data by Sex
However, women are significantly better represented in clinical trials
African-American Participation Inadequate in Cancer Drug Trials
Consistent underrepresentation seen in clinical trials evaluating medications across major cancer types
Many of the Initial COVID-19 Treatment Trials Poorly Designed
One-third of trials do not include clinical end points; 97 randomized trials were open-label design
Prostate Cancer Trial Participants Overwhelmingly White
Since 1990, proportion of white participants in prostate cancer clinical trials has remained >80 percent
COVID-19 Pandemic Slowing Cancer Research
Findings based on survey of American Cancer Society research grantees
Fewer Children Enrolling in Pediatric Cancer Trials
Adolescent and young adult cancer patients underrepresented in clinical trials
Impact of COVID-19 on Oncology Clinical Trials Discussed
Recommendations for sustaining cancer care access include permanent expanded support for telehealth
